Literature DB >> 1869638

Tumor necrosis factor.

P E Wakefield1, W D James, C P Samlaska, M S Meltzer.   

Abstract

Tumor necrosis factor is important in systemic and cutaneous defense, homeostasis, and many disease states. The numerous and diverse effects of tumor necrosis factor are best understood when considered as concentration-dependent, with normal homeostasis progressing to defense followed by toxic effects. Understanding tumor necrosis factor is important for the dermatologist as more studies appear in our literature and potential clinical uses of tumor necrosis factor (and possible anti-tumor necrosis factor agents) are realized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869638     DOI: 10.1016/0190-9622(91)70102-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  17 in total

1.  TNFalpha therapy in psoriatic arthritis and psoriasis.

Authors:  P Mease
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

2.  Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation.

Authors:  Honglin Wang; Thorsten Peters; Daniel Kess; Anca Sindrilaru; Tsvetelina Oreshkova; Nico Van Rooijen; Athanasios Stratis; Andreas C Renkl; Cord Sunderkötter; Meinhard Wlaschek; Ingo Haase; Karin Scharffetter-Kochanek
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

3.  Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.

Authors:  A Zentner; J Rendl; I Grelle; R Dummer; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 4.  Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

Authors:  David Kane; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

5.  Mutual interactions between HIV-1 and cytokines in adherent cells during acute infection.

Authors:  A Dolei; C Serra; M V Arca; F Tilocca; M Pietravalle; L Alemanno; A Toniolo; F Ameglio
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Altered human monocyte/macrophage function after exposure to diesel exhaust particles.

Authors:  P Thomas; J Maerker; W Riedel; B Przybilla
Journal:  Environ Sci Pollut Res Int       Date:  1995-09       Impact factor: 4.223

7.  Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.

Authors:  M Kristensen; C Q Chu; D J Eedy; M Feldmann; F M Brennan; S M Breathnach
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

8.  Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions.

Authors:  P Ettehadi; M W Greaves; D Wallach; D Aderka; R D Camp
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes.

Authors:  K Paukkonen; A Naukkarinen; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

10.  Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.